Digital Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

May 2025 | 98 pages | ID: D2D0DDB32892EN
Prof Research

Abstracts

Digital Therapeutics Market Summary

Introduction and Market Overview

Digital therapeutics (DTx) are evidence-based software solutions designed to prevent, manage, or treat medical conditions, often delivered via mobile apps or web platforms. These solutions address chronic diseases, mental health disorders, and neurological conditions through behavioral interventions, remote monitoring, and personalized care. The market is propelled by the global burden of non-communicable diseases (NCDs), which cause 74% of deaths annually, and a mental health crisis affecting 1 billion people. The aging population, projected to reach 2.1 billion by 2050, and widespread smartphone penetration (66% of the global population in 2023) further drive adoption. DTx reduces healthcare costs, with solutions like BlueStar lowering diabetes-related expenses. The global DTx market is estimated at USD 5.0-9.0 billion in 2025, with a CAGR of 15.5%-20.3% through 2030.

Regional Market Trends

• North America: The U.S. dominates with strong regulatory support and high smartphone penetration, while Canada focuses on mental health DTx.
• Europe: Germany, France, and the UK lead with digital health policies, emphasizing chronic disease management.
• Asia Pacific: China and India see rapid growth due to rising chronic disease prevalence, with Japan prioritizing elderly care solutions.
• Rest of the World: Brazil expands DTx for public health, and the Middle East invests in scalable mental health platforms.

Application Analysis

• Chronic Diseases: Expected growth of 16.0%-20.8%, driven by diabetes and cardiovascular disease management. Trends focus on AI-driven monitoring.
• Mental Health: Projected growth of 15.7%-20.5%, linked to rising depression and anxiety cases. Advances emphasize cognitive behavioral therapy apps.
• Neurological Diseases: Anticipated growth of 15.3%-20.1%, tied to conditions like ADHD. Developments prioritize gamified interventions.
• Others: Expected growth of 15.0%-19.8%, covering addiction management. Trends highlight scalable behavioral therapies.

Type Analysis

• Software: Expected growth of 16.2%-21.0%, valued for flexibility in chronic disease management. Trends focus on AI integration.
• Device: Projected growth of 15.5%-20.3%, linked to wearables for real-time monitoring. Advances emphasize IoT connectivity.
• Storage System: Anticipated growth of 15.0%-19.8%, supporting data-driven DTx platforms. Trends highlight cloud-based scalability.

Key Market Players

• Pear Therapeutics: Develops DTx for substance use disorders.
• Akili Interactive Labs: Focuses on neurological condition therapies.
• Welldoc: Offers diabetes management solutions.
• BigHealth: Provides mental health DTx platforms.
• OMADA HEALTH: Emphasizes chronic disease prevention.

Porter’s Five Forces Analysis

• Threat of New Entrants: High, due to low barriers for software development, but clinical validation poses challenges.
• Threat of Substitutes: Moderate, with traditional therapies competing, but DTx offers scalability.
• Bargaining Power of Buyers: Moderate, as patients seek affordable solutions, but clinical efficacy limits options.
• Bargaining Power of Suppliers: Low, with multiple software and cloud providers.
• Competitive Rivalry: High, with players competing on clinical outcomes and user engagement.

Market Opportunities and Challenges

Opportunities:

• Addressing NCDs, affecting 41 million annually, with scalable solutions.
• Tackling mental health issues, impacting 1 billion people, with accessible apps.
• Supporting an aging population with remote monitoring.
• Leveraging smartphone penetration for global reach.
• Aligning with WHO’s digital health strategy for regulatory support.
• Reducing healthcare costs, with DTx lowering diabetes expenses.

Challenges:

• Regulatory hurdles, requiring FDA and EMA approvals.
• Limited reimbursement models in developing regions.
• Patient adherence issues with digital interventions.
• Data privacy concerns, necessitating GDPR compliance.
• Competition from traditional therapies in mental health.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Digital Therapeutics Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST DIGITAL THERAPEUTICS MARKET IN NORTH AMERICA (2020-2030)

8.1 Digital Therapeutics Market Size
8.2 Digital Therapeutics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Digital Therapeutics Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST DIGITAL THERAPEUTICS MARKET IN SOUTH AMERICA (2020-2030)

9.1 Digital Therapeutics Market Size
9.2 Digital Therapeutics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Digital Therapeutics Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST DIGITAL THERAPEUTICS MARKET IN ASIA & PACIFIC (2020-2030)

10.1 Digital Therapeutics Market Size
10.2 Digital Therapeutics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Digital Therapeutics Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST DIGITAL THERAPEUTICS MARKET IN EUROPE (2020-2030)

11.1 Digital Therapeutics Market Size
11.2 Digital Therapeutics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Digital Therapeutics Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST DIGITAL THERAPEUTICS MARKET IN MEA (2020-2030)

12.1 Digital Therapeutics Market Size
12.2 Digital Therapeutics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Digital Therapeutics Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL DIGITAL THERAPEUTICS MARKET (2020-2025)

13.1 Digital Therapeutics Market Size
13.2 Digital Therapeutics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Digital Therapeutics Market Size by Type

CHAPTER 14 GLOBAL DIGITAL THERAPEUTICS MARKET FORECAST (2025-2030)

14.1 Digital Therapeutics Market Size Forecast
14.2 Digital Therapeutics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Digital Therapeutics Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Pear Therapeutics
  15.1.1 Company Profile
  15.1.2 Main Business and Digital Therapeutics Information
  15.1.3 SWOT Analysis of Pear Therapeutics
  15.1.4 Pear Therapeutics Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.2 Akili Interactive Labs
  15.2.1 Company Profile
  15.2.2 Main Business and Digital Therapeutics Information
  15.2.3 SWOT Analysis of Akili Interactive Labs
  15.2.4 Akili Interactive Labs Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.3 Welldoc
  15.3.1 Company Profile
  15.3.2 Main Business and Digital Therapeutics Information
  15.3.3 SWOT Analysis of Welldoc
  15.3.4 Welldoc Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.4 BigHealth
  15.4.1 Company Profile
  15.4.2 Main Business and Digital Therapeutics Information
  15.4.3 SWOT Analysis of BigHealth
  15.4.4 BigHealth Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.5 OMADA HEALTH
  15.5.1 Company Profile
  15.5.2 Main Business and Digital Therapeutics Information
  15.5.3 SWOT Analysis of OMADA HEALTH
  15.5.4 OMADA HEALTH Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.6 2Morrow
  15.6.1 Company Profile
  15.6.2 Main Business and Digital Therapeutics Information
  15.6.3 SWOT Analysis of 2Morrow
  15.6.4 2Morrow Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.7 ResMed
  15.7.1 Company Profile
  15.7.2 Main Business and Digital Therapeutics Information
  15.7.3 SWOT Analysis of ResMed
  15.7.4 ResMed Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.8 Fitbit LLC
  15.8.1 Company Profile
  15.8.2 Main Business and Digital Therapeutics Information
  15.8.3 SWOT Analysis of Fitbit LLC
  15.8.4 Fitbit LLC Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.9 Teladoc Health
  15.9.1 Company Profile
  15.9.2 Main Business and Digital Therapeutics Information
  15.9.3 SWOT Analysis of Teladoc Health
  15.9.4 Teladoc Health Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
15.10 CANARY HEALTH
  15.10.1 Company Profile
  15.10.2 Main Business and Digital Therapeutics Information
  15.10.3 SWOT Analysis of CANARY HEALTH
  15.10.4 CANARY HEALTH Digital Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Digital Therapeutics Report
Table Data Sources of Digital Therapeutics Report
Table Major Assumptions of Digital Therapeutics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Digital Therapeutics Picture
Table Digital Therapeutics Classification
Table Digital Therapeutics Applications
Table Drivers of Digital Therapeutics Market
Table Restraints of Digital Therapeutics Market
Table Opportunities of Digital Therapeutics Market
Table Threats of Digital Therapeutics Market
Table Covid-19 Impact For Digital Therapeutics Market
Table Raw Materials Suppliers
Table Different Production Methods of Digital Therapeutics
Table Cost Structure Analysis of Digital Therapeutics
Table Key End Users
Table Latest News of Digital Therapeutics Market
Table Merger and Acquisition
Table Planned/Future Project of Digital Therapeutics Market
Table Policy of Digital Therapeutics Market
Table 2020-2030 North America Digital Therapeutics Market Size
Figure 2020-2030 North America Digital Therapeutics Market Size and CAGR
Table 2020-2030 North America Digital Therapeutics Market Size by Application
Table 2020-2025 North America Digital Therapeutics Key Players Revenue
Table 2020-2025 North America Digital Therapeutics Key Players Market Share
Table 2020-2030 North America Digital Therapeutics Market Size by Type
Table 2020-2030 United States Digital Therapeutics Market Size
Table 2020-2030 Canada Digital Therapeutics Market Size
Table 2020-2030 Mexico Digital Therapeutics Market Size
Table 2020-2030 South America Digital Therapeutics Market Size
Figure 2020-2030 South America Digital Therapeutics Market Size and CAGR
Table 2020-2030 South America Digital Therapeutics Market Size by Application
Table 2020-2025 South America Digital Therapeutics Key Players Revenue
Table 2020-2025 South America Digital Therapeutics Key Players Market Share
Table 2020-2030 South America Digital Therapeutics Market Size by Type
Table 2020-2030 Brazil Digital Therapeutics Market Size
Table 2020-2030 Argentina Digital Therapeutics Market Size
Table 2020-2030 Chile Digital Therapeutics Market Size
Table 2020-2030 Peru Digital Therapeutics Market Size
Table 2020-2030 Asia & Pacific Digital Therapeutics Market Size
Figure 2020-2030 Asia & Pacific Digital Therapeutics Market Size and CAGR
Table 2020-2030 Asia & Pacific Digital Therapeutics Market Size by Application
Table 2020-2025 Asia & Pacific Digital Therapeutics Key Players Revenue
Table 2020-2025 Asia & Pacific Digital Therapeutics Key Players Market Share
Table 2020-2030 Asia & Pacific Digital Therapeutics Market Size by Type
Table 2020-2030 China Digital Therapeutics Market Size
Table 2020-2030 India Digital Therapeutics Market Size
Table 2020-2030 Japan Digital Therapeutics Market Size
Table 2020-2030 South Korea Digital Therapeutics Market Size
Table 2020-2030 Southeast Asia Digital Therapeutics Market Size
Table 2020-2030 Australia Digital Therapeutics Market Size
Table 2020-2030 Europe Digital Therapeutics Market Size
Figure 2020-2030 Europe Digital Therapeutics Market Size and CAGR
Table 2020-2030 Europe Digital Therapeutics Market Size by Application
Table 2020-2025 Europe Digital Therapeutics Key Players Revenue
Table 2020-2025 Europe Digital Therapeutics Key Players Market Share
Table 2020-2030 Europe Digital Therapeutics Market Size by Type
Table 2020-2030 Germany Digital Therapeutics Market Size
Table 2020-2030 France Digital Therapeutics Market Size
Table 2020-2030 United Kingdom Digital Therapeutics Market Size
Table 2020-2030 Italy Digital Therapeutics Market Size
Table 2020-2030 Spain Digital Therapeutics Market Size
Table 2020-2030 Belgium Digital Therapeutics Market Size
Table 2020-2030 Netherlands Digital Therapeutics Market Size
Table 2020-2030 Austria Digital Therapeutics Market Size
Table 2020-2030 Poland Digital Therapeutics Market Size
Table 2020-2030 Russia Digital Therapeutics Market Size
Table 2020-2030 MEA Digital Therapeutics Market Size
Figure 2020-2030 MEA Digital Therapeutics Market Size and CAGR
Table 2020-2030 MEA Digital Therapeutics Market Size by Application
Table 2020-2025 MEA Digital Therapeutics Key Players Revenue
Table 2020-2025 MEA Digital Therapeutics Key Players Market Share
Table 2020-2030 MEA Digital Therapeutics Market Size by Type
Table 2020-2030 Egypt Digital Therapeutics Market Size
Table 2020-2030 Israel Digital Therapeutics Market Size
Table 2020-2030 South Africa Digital Therapeutics Market Size
Table 2020-2030 Gulf Cooperation Council Countries Digital Therapeutics Market Size
Table 2020-2030 Turkey Digital Therapeutics Market Size
Table 2020-2025 Global Digital Therapeutics Market Size by Region
Table 2020-2025 Global Digital Therapeutics Market Size Share by Region
Table 2020-2025 Global Digital Therapeutics Market Size by Application
Table 2020-2025 Global Digital Therapeutics Market Share by Application
Table 2020-2025 Global Digital Therapeutics Key Vendors Revenue
Figure 2020-2025 Global Digital Therapeutics Market Size and Growth Rate
Table 2020-2025 Global Digital Therapeutics Key Vendors Market Share
Table 2020-2025 Global Digital Therapeutics Market Size by Type
Table 2020-2025 Global Digital Therapeutics Market Share by Type
Table 2025-2030 Global Digital Therapeutics Market Size by Region
Table 2025-2030 Global Digital Therapeutics Market Size Share by Region
Table 2025-2030 Global Digital Therapeutics Market Size by Application
Table 2025-2030 Global Digital Therapeutics Market Share by Application
Table 2025-2030 Global Digital Therapeutics Key Vendors Revenue
Figure 2025-2030 Global Digital Therapeutics Market Size and Growth Rate
Table 2025-2030 Global Digital Therapeutics Key Vendors Market Share
Table 2025-2030 Global Digital Therapeutics Market Size by Type
Table 2025-2030 Digital Therapeutics Global Market Share by Type